Forklaring af de grundlæggende farmakologiske mekanismer bag de forskellige behandlinger af skizofreni som påvirker dopaminsystemet. Hvad indebærer det, at et stof fungerer som en partiel agonist i stedet for en ren receptorantagonist, og hvilke fordele kan det have?
Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
Not located in Brazil? Go to a different regional HUB